A recent study analyzed the relationship between serum S100A8/S100A9 and S100A12 and the maintenance of clinical inactive disease (CID) in patients with polyarticular forms of juvenile idiopathic arthritis (PF-JIA) while on anti-TNF- therapy and disease flare following withdrawal of treatment. The gene discussed is TNF; the disease is juvenile idiopathic arthritis.